Coastlands Capital LP bought $319K of BOLT stock
By AlphaYouPublished Form 4
Coastlands Capital LP
Reporting filer
Coastlands Capital LP reported buying 50,000 shares of Bolt Biotherapeutics, Inc. for about $319K ($6.38 a share on average). Form 4 filed Nov 10, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 10, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Coastlands Capital LP | 2026-11-09 | P | Purchase | 50000 | 6.38 | 462,416 | 1 day | Filed terms
|
Common Stock
- Owner
- Coastlands Capital LP
- Date
- 2026-11-09
- Code
- P
- Action
- Purchase
- Quantity
- 50000
- Price
- 6.38
- Following holdings
- 462,416
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 50000
- transaction Price Per Share: 6.38
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 462416
- direct Or Indirect Ownership: I
- nature Of Ownership: By Coastlands Capital LP
- id: F2
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Coastlands Capital LP: 10% owner.
- F1: The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $6.3618 to $6.4044. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.
- F2: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.
Original sources
Prepared automatically from public filing data. Report a correction.